Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970101_sep96_decls2_0009.txt
Subject: INTERIM MEDICAL DOCTRINE TACTICS TECHNIQUES
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: BIOLOGICAL WARFARE DEFENSE FOR OPERATION DESERT STORM-1
Document Number: 1
Folder Seq #: 34
UNCLASSIFIED UNCLASSIFIED
SE6RE+
3
Desert Store the wafied series is given at day 0 and 14. Significant
RIOli)GICAL l@s of antibody and a ve level against @ can be two
GN, DIAGNOSIS, AND after the dose.
3-1. (u) Fhvsical @ion tram BiolocliCll Warfare Rm primary (2) (U) After all United States @ have been vaccinated with
defensive EFA @ are @vich@l icn (protective two @, @ %4 will @ve a third vaccination @ at least two
@ an[) @cal protective /battle dress ov ); act7,ve after the second dose to on.
shelter, ship, and plane protection; and collective p@icn (M51 for
battalion aid staticrvdivisicn clearing, the XM28 for @ @pped b. @@imn Toyin, BotLilimm vaccine (tcxoid) @d be given in
hospitals, and M20 for the GP l@ of the hospital care wards). 0.5 ml @ @ y at day 0, 14, and 84 (week 3.2) with
ve levels of @ @iqW two @ following the @
a. (u) Active Shelter @ion. consists of tents, GP dose. @ dose is given at one year intervals as needed in the ADR.
tents, and IW Items to m@ze JU agent entry. Desert chmical vapor
@Y ProviN @ revealed tlmt s@ed @ters using 3-3. (U) Di@is/ icn,
field @Wm (tape and @uq @ter Wm with earth) aff=W
significant protection against vapor agent Penetration. Protection factors a.
of 60 for @ tents, 20 for GP @ter without @ liner, 30 for GP
with liner, and greater than 60 for ISO shelters @ doclnnented. (1) (U) Signs and are malaim, fatigue, @e pain, mild
'Ibis that for @ GP without mttcn liner, the inside @tion is fever, ive cao with @icn to and @; widened
1/20 of the outside @tion. For @ tents the inside @tion on @ X-ray is characteristic.
is 1/60 of the @ide concentration. Ventilation sy@ @ be off during
Potential @t periods. Active sister p@on does not eliminate the (2) @An@ Blood (AB) @. libe AB test is to provide a
for individual p@icn. prel@ detection test to @e @ical to ve
clinical of anth=. Oonfirmaticn by alternative laboratory @
b. (U) Ships and Aircraft. Based on the sane @-alts of the @y is @ial. See Para 2-3. AB test is @ called the SKW Colorimetric
ftwuv Ground @, ships and aircraft when @ed @d afford Antigen @t. For ordering @ it is called the Test Kit
significant P icn against BW agents. Ventilation @d be NSN 6550-01-332-6755, unit of is kit, 25 tests Per
d be positioned at all macal trea@ facilities
the ACR. Fbr the Navy the AB test should be positicred at the
c- (u) Buildings of cppo@ty can also be partially Pleat Hospital arxl the next lower @on of @iaa care. AB tests should
ha@ by tapug and @liM @ windows, vents, electrical @ets, be refrigerated, but stability has @ it to be stable for one year
false ceilings, @ other /break, to the @ide. Ventilation m,@ at room ture and at least six @ at @ of 450 C (113c'
be off during @ial @t periods. F). In:licators for use of the AD test are as folimm:
3-2. @Xacci_mtion._ vaocinatim is available, on @ted basis, for (a) (u) Cluster of SMs with respiratory
administration to SMs @ @ COMM Priorities. As @im @ (febrile respiratory @, sudden @ in the @ a@ of
be0cm available, all United States Ebrces will be vaccinated. Medical operations at the same tim, rapid @icn to str@ and respiratory
la@tory , health care Providers, and the NBC t,@ @ with imdfic@, wide wftastimn on chest X-ray with ard/or without pulmonary
the BW detection mission should receive Om of the hi@ Priorities for effusicn without infiltrates).
arthrax and botulinl%m vaccination. These @ will @ially hardle
and process BW @les and/or care for UA Patients. @ e SM mm (b) or @ anthrax respiratory disease risk or
R.
exe=ise @ in the mmg@ and handling of blood sampler and
fluids of @tic @ pti@,@. (c) (U) Trained cyanotic @iratory deaths, acute
respiratory failure or insufficiency
a. @Anthrax.
(d) (U) Unexplained illness and @th.
(1) @ she anthrax vaccine (0.5 ml @) is given at day 0, 14,
and 28 with 3 additional doses given at six intervals. For operation
3-1 3-2
[ORPDE:T UNCLASSIFIED
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 16 f:/Week-36/BX003203/BIOLOGICAL WARFARE DEFENSE FOR OPERATION DESERT STORM-1/interim medical doctrine tactics techniques:1224960931153
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIOLOGICAL WARFARE DEFENSE FOR OPERATION DESERT STORM-1
Folder Seq # = 34
Subject = INTERIM MEDICAL DOCTRINE TACTICS TECHNIQUES
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996